Pyridine

Pyridine

SCHEMBL18007665

Cc1ccc(S(=O)(=O)O)o1.c1ccncc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.39
CA2 P00918 1/20 0.39
PHLPP2 Q6ZVD8 1/20 0.38
NAPRT Q6XQN6 1/20 0.38
HTT P42858 1/20 0.37
CCR2 P41597 3/20 0.35
ALDH1A1 P00352 5/20 0.33
HPGD P15428 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
KDM4E B2RXH2 3/20 0.33
TDP1 Q9NUW8 2/20 0.33
RAB9A P51151 1/20 0.33
BLM P54132 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
TSHR P16473 1/20 0.32
HSD17B10 Q99714 2/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3468425 0.85 TDP1 (0.46) CA1CA2PHLPP2CCR2ALDH1A1
SCHEMBL11050586 0.83 TDP1 (0.43) CA1CA2PHLPP2CCR2ALDH1A1
Hydrochloric Acid SCHEMBL11049903 0.83 TDP1 (0.43) CA1CA2PHLPP2CCR2ALDH1A1
Pyridine SCHEMBL18007597 0.79 CA1 (0.49) CA1CA2PHLPP2NAPRTALDH1A1
Pyridine SCHEMBL28184552 0.71 NAPRT (0.40) PHLPP2NAPRTALDH1A1HPGDSMN1; SMN2
Toluene SCHEMBL6514880 0.70 TSHR (0.48) CA1CA2NAPRTHTTALDH1A1
Toluene SCHEMBL512992 0.70 TSHR (0.48) CA1CA2NAPRTHTTALDH1A1
SCHEMBL13826361 0.70 CA1 (0.46) CA1CA2PHLPP2NAPRTHTT
Pyridine SCHEMBL20958 0.69 ALDH1A1 (0.58) NAPRTHTTALDH1A1HPGDSMN1; SMN2
Pyridine SCHEMBL6427981 0.69 ALDH1A1 (0.58) NAPRTHTTALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400502-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME UNIV QUEENSLAND (AU) 2024-12-05 US disclosed
CN-113582889-B Sulfonylureas and related compounds and uses thereof 昆士兰大学 2024-09-20 CN disclosed
US-11845715-B2 2023-12-19 US disclosed
US-20220112159-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME UNIV QUEENSLAND (AU) 2022-04-14 US disclosed
CN-113582889-A Sulfonylureas and related compounds and uses thereof 昆士兰大学 2021-11-02 CN disclosed
CN-113563264-A Sulfonylureas and related compounds and uses thereof 昆士兰大学 2021-10-29 CN disclosed
EP-3888749-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME The University of Queensland (AU) 2021-10-06 EP disclosed
US-11130731-B2 Sulfonylureas and related compounds and use of same THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2021-09-28 US disclosed
CN-107428696-B Sulfonylureas and related compounds and uses thereof 昆士兰大学 2021-08-20 CN disclosed
EP-3578547-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME The University of Queensland (AU) 2019-12-11 EP disclosed
US-20180044287-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME INFLAZOME LIMITED (IE) 2018-02-15 US disclosed
EP-3259253-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME The University of Queensland (AU) 2017-12-27 EP disclosed
WO-2016131098-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME THE UNIVERSITY OF QUEENSLAND (AU) 2016-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220112159-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP CA1 4141/4885CA2 2434/4885PHLPP2 580/4885
US-11845715-B2 NLRP3, PYCARD, NOD1 CA1 4541/4885CA2 3818/4885PHLPP2 729/4885
US-11130731-B2 Sulfonylureas and related compounds and use of same NLRP3, PYCARD, IAPP CA1 4141/4885CA2 2434/4885PHLPP2 580/4885
US-20240400502-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP CA1 4141/4885CA2 2434/4885PHLPP2 580/4885
US-20180044287-A1 SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME NLRP3, PYCARD, IAPP CA1 4141/4885CA2 2434/4885PHLPP2 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.